Thomas K. Hansen

2.8k total citations · 1 hit paper
71 papers, 2.1k citations indexed

About

Thomas K. Hansen is a scholar working on Electronic, Optical and Magnetic Materials, Endocrinology, Diabetes and Metabolism and Organic Chemistry. According to data from OpenAlex, Thomas K. Hansen has authored 71 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Electronic, Optical and Magnetic Materials, 20 papers in Endocrinology, Diabetes and Metabolism and 19 papers in Organic Chemistry. Recurrent topics in Thomas K. Hansen's work include Organic and Molecular Conductors Research (22 papers), Magnetism in coordination complexes (15 papers) and Diabetes Treatment and Management (14 papers). Thomas K. Hansen is often cited by papers focused on Organic and Molecular Conductors Research (22 papers), Magnetism in coordination complexes (15 papers) and Diabetes Treatment and Management (14 papers). Thomas K. Hansen collaborates with scholars based in Denmark, United Kingdom and United States. Thomas K. Hansen's co-authors include Jan Becher, Stephen C. Bain, Julie Derving Karsbøl, Christopher Sorli, George Tsoukas, Jeffrey Unger, Shin‐ichi Harashima, Martin R. Bryce, Nathalie Schlienger and Paul C. Stein and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Diabetes Care.

In The Last Decade

Thomas K. Hansen

65 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial

2017 496 citations Christopher Sorli, Shin‐ichi Harashima et al. The Lancet Diabetes & Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas K. Hansen Denmark	26	817	639	534	460	311	71	2.1k
Nandita Biswas India	23	291 0.4×	448 0.7×	276 0.5×	389 0.8×	482 1.5×	42	1.7k
Michael Wagner Germany	30	471 0.6×	936 1.5×	62 0.1×	757 1.6×	235 0.8×	117	2.6k
Ga‐Lai Law Hong Kong	43	484 0.6×	542 0.8×	1.3k 2.4×	716 1.6×	3.2k 10.3×	105	4.6k
Maggie Ng Hong Kong	42	721 0.9×	855 1.3×	208 0.4×	823 1.8×	1.6k 5.2×	136	4.5k
William B. Smith United States	28	280 0.3×	514 0.8×	56 0.1×	847 1.8×	144 0.5×	161	2.8k
Jennifer L. Reid United States	19	264 0.3×	1.3k 2.0×	131 0.2×	427 0.9×	405 1.3×	31	2.7k
Tatsuya Fujino Japan	18	400 0.5×	508 0.8×	66 0.1×	147 0.3×	476 1.5×	65	2.0k
Lorenzo Franco Italy	27	69 0.1×	405 0.6×	382 0.7×	478 1.0×	884 2.8×	104	2.6k
Y. Sasaki Japan	18	189 0.2×	140 0.2×	326 0.6×	144 0.3×	224 0.7×	34	1.3k
Hideo Kurosawa Japan	43	148 0.2×	413 0.6×	474 0.9×	5.1k 11.1×	605 1.9×	266	6.2k

Countries citing papers authored by Thomas K. Hansen

Since Specialization

Citations

This map shows the geographic impact of Thomas K. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas K. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas K. Hansen more than expected).

Fields of papers citing papers by Thomas K. Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas K. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas K. Hansen. The network helps show where Thomas K. Hansen may publish in the future.

Co-authorship network of co-authors of Thomas K. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas K. Hansen. A scholar is included among the top collaborators of Thomas K. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas K. Hansen. Thomas K. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hansen, Thomas K., Piaoping Yang, Abhijit Shrotri, et al.. (2025). Reversible temperature-induced shape transition of Pt nanoparticles supported on Al ₂ O ₃. Nanoscale Advances. 8(2). 504–512.

Norman, S., et al.. (2024). A 10-year review of presentation, management and outcomes of STEMI in a high-volume regional tertiary Australian centre. International Journal of Cardiology. 410. 132224–132224.

Leiter, Lawrence A., Stephen C. Bain, Irene Hramiak, et al.. (2019). Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial. Cardiovascular Diabetology. 18(1). 73–73. 86 indexed citations

Nauck, Michael A., Raymond de la Rosa, Michel Marre, et al.. (2019). Minimal contribution of nausea or vomiting to superior semaglutide-mediated weight loss vs. exenatide and dulaglutide in type 2 diabetes. Diabetologie und Stoffwechsel. 1 indexed citations

Sorli, Christopher, Shin‐ichi Harashima, George Tsoukas, et al.. (2017). Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. The Lancet Diabetes & Endocrinology. 5(4). 251–260. 496 indexed citations breakdown →

Jørgensen, Jørgen J., et al.. (2017). The Norwegian guidelines for the prehospital management of adult trauma patients with potential spinal injury. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 25(1). 2–2. 60 indexed citations

Hansen, Thomas K., Martin Høj, Brian Brun Hansen, Ton V. W. Janssens, & Anker Degn Jensen. (2017). The Effect of Pt Particle Size on the Oxidation of CO, C3H6, and NO Over Pt/Al2O3 for Diesel Exhaust Aftertreatment. Topics in Catalysis. 60(17-18). 1333–1344. 43 indexed citations

Bernsen, Niels Ole, et al.. (2006). Field Evaluation of a Single-Word Pronunciation Training System. Language Resources and Evaluation. 2068–2073. 2 indexed citations

Østergård, Torben, Jakob Ek, Bengt Saltin, et al.. (2005). Influence of the PPAR-γ2 Pro12Ala and ACE I/D Polymorphisms on Insulin Sensitivity and Training Effects in Healthy Offspring of Type 2 Diabetic Subjects. Hormone and Metabolic Research. 37(2). 99–105. 31 indexed citations

10.

Buddington, Karyl K., et al.. (2003). Absorption and systemic availability of two synthetic growth hormone secretogogues and transport of glucose by the proximal small intestine of anestrus dogs after administering estradiol. Journal of Comparative Physiology B. 173(1). 61–67. 1 indexed citations

11.

Djurhuus, Christian, Thomas K. Hansen, Jens J. Holst, & Ole Schmitz. (2002). Feast or Famine - Are GLP-1 and Ghrelin Secretion Intertwined?. Hormone and Metabolic Research. 34(7). 353–354. 5 indexed citations

12.

Hansen, Thomas K., Michael Ankersen, Kirsten Raun, & Birgit Sehested Hansen. (2001). Highly potent growth hormone secretagogues: Hybrids of NN703 and ipamorelin. Bioorganic & Medicinal Chemistry Letters. 11(14). 1915–1918. 7 indexed citations

13.

Schlienger, Nathalie, Martin R. Bryce, & Thomas K. Hansen. (2000). Heterocyclic aldehydes as novel components in the boronic Mannich reaction. Tetrahedron Letters. 41(8). 1303–1305. 34 indexed citations

14.

Ankersen, Michael, Nils L. Johansen, Kjeld Madsen, et al.. (1998). A New Series of Highly Potent Growth Hormone-Releasing Peptides Derived from Ipamorelin. Journal of Medicinal Chemistry. 41(19). 3699–3704. 27 indexed citations

15.

Roncali, Jean, Lennart Rasmussen, Christine Thobie‐Gautier, et al.. (1994). Effects of structure on the optical and redox properties of the oligothiophene— Tetrathiafulvalene hybrid system. Advanced Materials. 6(11). 841–845. 34 indexed citations

16.

Hansen, Thomas K., Tine Jørgensen, & Jan Becher. (1992). A sodium ion-sensitive tetrathiafulvalene: preparation and redox properties. Journal of the Chemical Society Chemical Communications. 1550–1552. 18 indexed citations

17.

Becher, Jan, Thomas K. Hansen, Tine Jørgensen, & Paul C. Stein. (1992). Heterocyclic π‐Donors, Macrocycles and Cage Molecules. Bulletin des Sociétés Chimiques Belges. 101(7). 555–568. 3 indexed citations

18.

Hansen, Thomas K., et al.. (1992). Novel maleimide-type acceptors based on annelated 1,4-dithiins. Journal of the Chemical Society Perkin Transactions 1. 1807–1807. 3 indexed citations

19.

Hyde, Stephen T., Arndt Simon, Søren Bøwadt, et al.. (1991). Hyperbolic Surfaces in the Solid State and the Structure of ZSM-5 Zeolites.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 45. 860–863. 5 indexed citations

20.

Roepstorff, Peter, et al.. (1990). Alkali metal ion complexation of crown ethers and related ligands studied by californium-252 plasma desorption mass spectrometry. Journal of the American Chemical Society. 112(9). 3709–3710. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact